By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today announced a 17 percent increase in third-quarter revenues as grant revenues rose 57 percent.

For the three months ended Sept. 30, the sample prep technology firm reported total revenues of $372,103, up from $317,427 a year ago, falling short of Wall Street estimates of $420,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.